4.0
Mar 14, 2014
Typical big pharma in 'new millennia'.
Former employee, more than 10 years
Raleigh, NC
Recommend
CEO approval
Business Outlook
Pros
Market leader in anti-platelet, anti-thrombotic, and diabetes disease states.
Cons
Joint venture co-promotions often lead to 'too many coaches on the sidelines' and convoluted 'game plans' for success. Annual field staffing/realignment efforts routinely negatively affecting sales professionals morale. Very mature product portfolio, impending patent cliffs for several 'blockbusters', failed new molecule development.